Digital and information transformation is one of the hottest topics in all industries in recent years, as is the pharmaceutical industry. In the industrial 4.0 era, with the rapid development of big data, cloud computing, artificial intelligence and other technologies, the wave of digitalization is penetrating into every corner of the pharmaceutical industry. Digital transformation has also become an inevitable choice for relevant enterprises to stand out and seek high-quality development in the new market environment.
For cdmo industry, industry 4.0 is not a vague concept, but a grim reality. Using intelligent and automated systems to control the manufacturing process is an important way for cdmo enterprises to meet increasingly stringent customer and regulatory needs and seize opportunities in emerging markets. As an expert in the manufacturing field, cdmo, compared with other types of enterprises, should actively embrace industry 4.0, not only to help enterprises reduce costs and increase efficiency, but also to improve overall competitiveness.
On the other hand, cdmo plays the role of connecting upstream and downstream in the pharmaceutical field. It is an important direction to strengthen the construction of digitalization and informatization, improve the level of intelligent manufacturing, and help realize the digitalization transformation and transformation of the whole industrial chain of pharmaceutical R & D, production, compliance and circulation.
